美国 · SEC FORM 4
InspireMD, Inc.
NSPR · Nasdaq · CIK 0001433607 · Healthcare · Medical Devices
内部人信号
4 位买方 · 13 条买入交易行 · $454.1K 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ 角色得分低 · 买入者中职位最高的是:CEO and President(CEO、董事长和持股 10% 以上的股东得分最低)
- ⚠ Purchase activity is becoming less recent
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: CEO and President, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 65.7
- 65.6
- 65.5
- 65.5
- 65.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -33.3%
- 3M
- -27.8%
- 6M
- -59.7%
- 12M
- -78.7%
波动率与流动性
- 波动率
- 60.4%
- Beta
- —
- 平均每日成交额
- USD 42,397
估值
- 市值
- USD 24.2M
- P/E
- —
基本面
- 利润率
- -543.4%
- ROE
- -88.4%
- 细分行业
- Medical Devices
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:市值, 利润率, ROE · 财年截止日:2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期:2026-08-14 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 22,466
- 上期报告
- 25,364
- 日均成交量
- 70,548
- 回补天数
- ≤ 1.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Stuka Paul | 买入 (P) | Common Stock | 20,000 | USD 0.88 | USD 17,600 | SEC 申报 ↗ |
| 2026-05-14 | Stuka Paul | 买入 (P) | Common Stock | 5,000 | USD 1.15 | USD 5,750 | SEC 申报 ↗ |
| 2026-05-13 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.16 | USD 11,600 | SEC 申报 ↗ |
| 2026-05-12 | Slosman Marvin | 买入 (P) | Common Stock | 21,000 | USD 1.20 | USD 25,200 | SEC 申报 ↗ |
| 2026-05-11 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.19 | USD 11,900 | SEC 申报 ↗ |
| 2026-05-11 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.19 | USD 11,900 | SEC 申报 ↗ |
| 2026-05-08 | Stuka Paul | 买入 (P) | Common Stock | 65,626 | USD 1.16 | USD 76,126 | SEC 申报 ↗ |
| 2026-05-08 | Stuka Paul | 买入 (P) | Common Stock | 65,626 | USD 1.16 | USD 76,126 | SEC 申报 ↗ |
| 2026-05-07 | Ward Scott R. | 买入 (P) | Common Stock | 73,255 | USD 1.15 | USD 84,243 | SEC 申报 ↗ |
| 2026-05-07 | Stuka Paul | 买入 (P) | Common Stock | 6,378 | USD 1.15 | USD 7,335 | SEC 申报 ↗ |
| 2026-05-07 | ROUBIN GARY S | 买入 (P) | Common Stock | 90,000 | USD 1.18 | USD 106,200 | SEC 申报 ↗ |
| 2026-05-06 | Ward Scott R. | 买入 (P) | Common Stock | 15,995 | USD 1.15 | USD 18,394 | SEC 申报 ↗ |
| 2026-05-06 | Stuka Paul | 买入 (P) | Common Stock | 1,517 | USD 1.12 | USD 1,699 | SEC 申报 ↗ |
| 2025-12-09 | Stuka Paul | 买入 (P) | Common Stock | 2,710 | USD 1.81 | USD 4,905 | SEC 申报 ↗ |
| 2025-12-09 | Stuka Paul | 买入 (P) | Common Stock | 5,073 | USD 1.81 | USD 9,182 | SEC 申报 ↗ |
Form 4 申报证据
40 transaction lines in the latest 365-day window; 142 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Stuka Paul | 买入 (P) | Common Stock | 20,000 | USD 0.88 | USD 17,600 | SEC 申报 ↗ |
| 2026-05-19 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 22,778 | USD 1.01 | USD 23,006 | SEC 申报 ↗ |
| 2026-05-14 | Stuka Paul | 买入 (P) | Common Stock | 5,000 | USD 1.15 | USD 5,750 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Stuka Paul | 买入 (P) | Common Stock | 20,000 | USD 0.88 | USD 17,600 | SEC 申报 ↗ |
| 2026-05-19 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 22,778 | USD 1.01 | USD 23,006 | SEC 申报 ↗ |
| 2026-05-14 | Stuka Paul | 买入 (P) | Common Stock | 5,000 | USD 1.15 | USD 5,750 | SEC 申报 ↗ |
| 2026-05-13 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.16 | USD 11,600 | SEC 申报 ↗ |
| 2026-05-12 | Slosman Marvin | 买入 (P) | Common Stock | 21,000 | USD 1.20 | USD 25,200 | SEC 申报 ↗ |
| 2026-05-11 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.19 | USD 11,900 | SEC 申报 ↗ |
| 2026-05-11 | Stuka Paul | 买入 (P) | Common Stock | 10,000 | USD 1.19 | USD 11,900 | SEC 申报 ↗ |
| 2026-05-08 | Stuka Paul | 买入 (P) | Common Stock | 65,626 | USD 1.16 | USD 76,126 | SEC 申报 ↗ |
| 2026-05-08 | Stuka Paul | 买入 (P) | Common Stock | 65,626 | USD 1.16 | USD 76,126 | SEC 申报 ↗ |
| 2026-05-07 | Ward Scott R. | 买入 (P) | Common Stock | 73,255 | USD 1.15 | USD 84,243 | SEC 申报 ↗ |
| 2026-05-07 | Stuka Paul | 买入 (P) | Common Stock | 6,378 | USD 1.15 | USD 7,335 | SEC 申报 ↗ |
| 2026-05-07 | ROUBIN GARY S | 买入 (P) | Common Stock | 90,000 | USD 1.18 | USD 106,200 | SEC 申报 ↗ |
| 2026-05-06 | Ward Scott R. | 买入 (P) | Common Stock | 15,995 | USD 1.15 | USD 18,394 | SEC 申报 ↗ |
| 2026-05-06 | Stuka Paul | 买入 (P) | Common Stock | 1,517 | USD 1.12 | USD 1,699 | SEC 申报 ↗ |
| 2026-02-02 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 2,000 | USD 1.60 | USD 3,200 | SEC 申报 ↗ |
| 2026-01-30 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 2,900 | USD 1.63 | USD 4,727 | SEC 申报 ↗ |
| 2026-01-29 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 5,000 | USD 1.65 | USD 8,250 | SEC 申报 ↗ |
| 2026-01-28 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 12,395 | USD 1.65 | USD 20,452 | SEC 申报 ↗ |
| 2026-01-27 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 4,781 | USD 1.66 | USD 7,936 | SEC 申报 ↗ |
| 2026-01-22 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 8,411 | USD 1.57 | USD 13,205 | SEC 申报 ↗ |
| 2026-01-21 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 17,593 | USD 1.62 | USD 28,501 | SEC 申报 ↗ |
| 2026-01-20 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 2,955 | USD 1.59 | USD 4,698 | SEC 申报 ↗ |
| 2026-01-16 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 2,250 | USD 1.61 | USD 3,622 | SEC 申报 ↗ |
| 2026-01-15 | Gleason Shane Thomas | 卖出 (S) | Common Stock | 2,909 | USD 1.58 | USD 4,596 | SEC 申报 ↗ |
| 2026-01-14 | Ward Scott R. | 奖励/授予 (A) | Common Stock | 88,053 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-14 | Tommasoli Andrea | 奖励/授予 (A) | Common Stock | 226,695 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-14 | Stuka Paul | 奖励/授予 (A) | Common Stock | 132,076 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-14 | Slosman Marvin | 奖励/授予 (A) | Restricted Stock Units | 1,114,792 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-14 | ROUBIN GARY S | 奖励/授予 (A) | Common Stock | 88,053 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-14 | Lawless Michael A | 奖励/授予 (A) | Common Stock | 226,695 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NSPR |
| CIK | 0001433607 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 142 transaction lines from 2020-01-02 to 2026-05-27 46 P purchase lines · 11 S sale lines · 85 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.